Invesco Biotechnology & Genome ETF logo

Invesco Biotechnology & Genome ETF (PBE)

Market Closed
17 Jul, 20:00
ARCA ARCA
$
91. 03
-0.05
-0.0549%
$
270.9M Market Cap
0.03% Div Yield
800 Volume
$ 91.08
Previous Close
Add Transaction
Day Range
90.95 91.03
Year Range
63.92 94.06
Want to track PBE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

Launched on 06/23/2005, the Invesco Biotechnology & Genome ETF (PBE) is a smart beta exchange traded fund offering broad exposure to the Health Care ETFs category of the market.

Zacks | 1 year ago
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?

Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?

If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the Invesco Biotechnology & Genome ETF (PBE), a passively managed exchange traded fund launched on 06/23/2005.

Zacks | 1 year ago
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

The Invesco Biotechnology & Genome ETF (PBE) made its debut on 06/23/2005, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.

Zacks | 1 year ago
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?

Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?

If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the Invesco Biotechnology & Genome ETF (PBE), a passively managed exchange traded fund launched on 06/23/2005.

Zacks | 1 year ago
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

Launched on 06/23/2005, the Invesco Biotechnology & Genome ETF (PBE) is a smart beta exchange traded fund offering broad exposure to the Health Care ETFs category of the market.

Zacks | 1 year ago
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?

Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?

If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the Invesco Biotechnology & Genome ETF (PBE), a passively managed exchange traded fund launched on 06/23/2005.

Zacks | 1 year ago
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

The Invesco Biotechnology & Genome ETF (PBE) was launched on 06/23/2005, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.

Zacks | 1 year ago
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?

Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?

If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the Invesco Biotechnology & Genome ETF (PBE), a passively managed exchange traded fund launched on 06/23/2005.

Zacks | 1 year ago
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

Launched on 06/23/2005, the Invesco Biotechnology & Genome ETF (PBE) is a smart beta exchange traded fund offering broad exposure to the Health Care ETFs category of the market.

Zacks | 1 year ago
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?

Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?

Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the Invesco Biotechnology & Genome ETF (PBE) is a passively managed exchange traded fund launched on 06/23/2005.

Zacks | 2 years ago
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

The Invesco Biotechnology & Genome ETF (PBE) made its debut on 06/23/2005, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.

Zacks | 2 years ago